Skip to main content
. Author manuscript; available in PMC: 2017 Jul 17.
Published in final edited form as: Acta Biomater. 2017 Feb 16;53:109–122. doi: 10.1016/j.actbio.2017.02.020

Fig. 1.

Fig. 1

Released AT-RvD1 promotes macrophage phagocytosis and inhibits neutrophil myeloperoxidase (A-B) Brightfield and epifluorescence micrographs of RAW264.7 macrophages treated with PLGA film-conditioned media (PLGA CM) or AT-RvD1 conditioned media (PLGA-AT-RvD1 CM). White arrowheads indicate engulfed beads by macrophages. Scale bar, 5 mm (C) Quantification of phagocytic activity of RAW264.7 macrophages. (D) Myeloperoxidase activity of MPRO-differentiated neutrophils decreases significantly after treatment with AT-RvD1 conditioned media. Data presented as mean ± S.E.M. Statistical analyses were performed using two-tailed t-tests *p < 0.05, **p < 0.01 n = 3 samples per group.